Orchard Therapeutics North America lobbies on its own behalf. For Q3 2026 it reported $240K across 1 client report and lists 2 lobbyists across its filings. Issues include Health Issues and Medicare/Medicaid.
| Client | Reported | Issues |
|---|---|---|
| ORCHARD THERAPEUTICS NORTH AMERICA | $240K | Health Issues, Medicare/Medicaid |
| Year | Reported | Clients |
|---|---|---|
| 2026 | $900K | 1 |
| 2025 | $1.18M | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.